The OPK chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the OPK chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The OPK stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View OPK Detailed Price Forecast - CNN Money||View OPK Detailed Summary - Google Finance|
|View OPK Detailed Summary - Yahoo! Finance||View OPK Stock Research & Analysis - Zacks.com|
|View OPK Trends & Analysis - Trade-Ideas||View OPK Major Holders - Barrons|
|View OPK Call Transcripts - NASDAQ||View OPK Breaking News & Analysis - Seeking Alpha|
|View OPK Annual Report - CompanySpotlight.com||View OPK OTC Short Report - OTCShortReport.com|
|View OPK Fundamentals - TradeKing||View OPK SEC Filings - Bar Chart|
|View Historical Prices for OPK - The WSJ||View Performance/Total Return for OPK - Morningstar|
|View the Analyst Estimates for OPK - MarketWatch||View the Earnings History for OPK - CNBC|
|View the OPK Earnings - StockMarketWatch||View OPK Buy or Sell Recommendations - MacroAxis|
|View the OPK Bullish Patterns - American Bulls||View OPK Short Pain Metrics - ShortPainBot.com|
|View OPK Stock Mentions - StockTwits||View OPK Stock Mentions - PennyStockTweets|
|View OPK Stock Mentions - Twitter||View OPK Investment Forum News - Investor Hub|
|View OPK Stock Mentions - Yahoo! Message Board||View OPK Stock Mentions - Seeking Alpha|
|View Insider Transactions for OPK - SECform4.com||View Insider Transactions for OPK - Insider Cow|
|View OPK Major Holdings Summary - CNBC||View Insider Disclosure for OPK - OTC Markets|
|View Insider Transactions for OPK - Yahoo! Finance||View Institutional Holdings for OPK - NASDAQ|
|View OPK Stock Insight & Charts - FinViz.com||View OPK Investment Charts - StockCharts.com|
|View OPK Stock Overview & Charts - BarChart||View OPK User Generated Charts - Trading View|
GeneDx Announces Completion of 100,000 Exome Sequences
Posted on Tuesday June 12, 2018
Exome sequencing is a process by which the protein-coding genes in the human genome are sequenced. It is used to help diagnose disease by identifying variations in these genes that may lead to a variety of neurological, metabolic or other disorders. Over the past three years, GeneDx has helped discover and publish more than 62 disease-causing genes, thereby contributing to the phenotypic, or observable characteristics, involved in identifying and further understanding developmental delay and intellectual disability. GeneDx has grown in exome volume by a compound annual growth rate of 55% since its inception. With over 100 professionals dedicated to exomes and genomes, including MDs, PhDs and genetic counselors, GeneDx has developed a suite of patient-focused exome and genome tests for a variety of clinical indications and scenarios, including family-based testing, rapid testing for critically ill patients, prenatal testing and exome testing in parallel with mitochondrial genetic testing.
Today's Research Reports on Trending Tickers: Valeant Pharmaceuticals and OPKO Health
Posted on Monday June 11, 2018
NEW YORK, NY / ACCESSWIRE / June 11, 2018 / U.S. markets finished higher and logged strongest week in months as investors shrug off tensions between U.S. and its allies. The Dow Jones Industrial Average ...
OPKO Health Completes Enrollment in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes and Obesity
Posted on Monday June 11, 2018
Based on preclinical and Phase 2 data, the use of the dual agonist, OPK88003, once-weekly with an optimized dosing regimen, could more effectively improve glucose control, increase weight loss and improve the lipid profile in type 2 diabetics compared with the currently available GLP-1 medicines.
Why OPKO Health, Inc. Stock Rocketed Higher in May
Posted on Saturday June 09, 2018
Opko's shares benefited from a better-than-expected first-quarter earnings release last month, but the company's good fortunes didn't last long.